Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Orange应助windli采纳,获得10
1秒前
小凤凤完成签到,获得积分10
1秒前
runzhi发布了新的文献求助10
1秒前
lruri完成签到,获得积分10
1秒前
zuoyou完成签到,获得积分10
2秒前
2秒前
3秒前
3秒前
wjqgdsvdja完成签到,获得积分10
3秒前
无忧发布了新的文献求助10
4秒前
4秒前
鸭爪爪发布了新的文献求助10
4秒前
英俊的铭应助帅气yumin采纳,获得10
5秒前
6秒前
wzswzs发布了新的文献求助10
6秒前
奶牛在吃豆完成签到,获得积分20
6秒前
调皮的如南完成签到,获得积分10
8秒前
yang完成签到,获得积分10
8秒前
搜集达人应助wyvern114采纳,获得10
8秒前
阿童木完成签到,获得积分10
9秒前
丘比特应助安妮采纳,获得10
9秒前
9秒前
llllllll完成签到 ,获得积分10
9秒前
xhDoc给xhDoc的求助进行了留言
10秒前
初雪发布了新的文献求助10
10秒前
10秒前
Orange应助风语过采纳,获得10
10秒前
SciGPT应助不安的醉薇采纳,获得10
10秒前
执念完成签到 ,获得积分10
10秒前
黄油小熊发布了新的文献求助10
11秒前
11秒前
许红祥完成签到,获得积分10
11秒前
布拉布拉完成签到,获得积分10
12秒前
Sue发布了新的文献求助10
12秒前
wzswzs完成签到,获得积分10
12秒前
12秒前
大个应助体贴沛柔采纳,获得10
13秒前
Mia完成签到 ,获得积分10
14秒前
徐梓睿发布了新的文献求助10
14秒前
高分求助中
The Wiley Blackwell Companion to Diachronic and Historical Linguistics 3000
HANDBOOK OF CHEMISTRY AND PHYSICS 106th edition 1000
ASPEN Adult Nutrition Support Core Curriculum, Fourth Edition 1000
Decentring Leadership 800
Signals, Systems, and Signal Processing 610
脑电大模型与情感脑机接口研究--郑伟龙 500
Genera Orchidacearum Volume 4: Epidendroideae, Part 1 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6288323
求助须知:如何正确求助?哪些是违规求助? 8107013
关于积分的说明 16959088
捐赠科研通 5353385
什么是DOI,文献DOI怎么找? 2844755
邀请新用户注册赠送积分活动 1821935
关于科研通互助平台的介绍 1678122